Pfizer Experts Escape Judge's Boot In Neurontin Case

By Christie Smythe

Law360, New York (February 16, 2010, 6:36 PM ET) -- A judge has rejected Kaiser Foundation Health Plan Inc.’s attempt to strike the testimony of a group of experts for Pfizer Inc. ahead of a trial over the drugmaker’s alleged off-label promotion of Neurontin, contending that there is simply not enough time to address Kaiser’s concerns.

Judge Patti B. Saris issued an order Friday in the U.S. District Court for the District of Massachusetts denying five of Kaiser’s motions to exclude the testimony of Pfizer's efficacy experts from the upcoming trial, which is scheduled to start...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles